U.S. Intrathecal Pumps Market Size & Outlook, 2022-2030
U.S. intrathecal pumps market, 2017-2030 (US$M)
Related Markets
U.S. intrathecal pumps market highlights
- The U.S. intrathecal pumps market generated a revenue of USD 110.9 million in 2022 and is expected to reach USD 154.9 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.3% from 2023 to 2030.
- In terms of segment, morphine was the largest revenue generating type in 2022.
- Bupivacaine is the most lucrative type segment registering the fastest growth during the forecast period.
Intrathecal pumps market data book summary
| Market revenue in 2022 | USD 110.9 million |
| Market revenue in 2030 | USD 154.9 million |
| Growth rate | 4.3% (CAGR from 2022 to 2030) |
| Largest segment | Morphine |
| Fastest growing segment | Bupivacaine |
| Historical data | 2017 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Baclofen, Bupivacaine, Clonidine, Morphine, Ziconotide, Other Type |
| Key market players worldwide | Medtronic PLC, Smiths Group PLC, Teleflex Inc, Johnson & Johnson, Medallion Therapeutics, Tricumed Medical Technology, Arrow International Inc, Flowonix |
Other key industry trends
- In terms of revenue, U.S. accounted for 32.4% of the global intrathecal pumps market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. intrathecal pumps market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 154.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Intrathecal Pumps Market Scope
Intrathecal Pumps Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. intrathecal pumps market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intrathecal pumps market will help companies and investors design strategic landscapes.
Morphine was the largest segment with a revenue share of 31.65% in 2022. Horizon Databook has segmented the U.S. intrathecal pumps market based on baclofen, bupivacaine, clonidine, morphine, ziconotide, other type covering the revenue growth of each sub-segment from 2017 to 2030.
Presence of a large patient pool for spinal surgery in the U.S. is expected to drive the demand for intrathecal pumps in the country. Therefore, market players focus on addressing the growing demand by launching intrathecal pumps.
In February 2020, Flowonix Medical received market approval from the U.S. FDA for Prometra II used with intrathecal baclofen. The pumps uses a valvegated, pressure-driven mechanism for delivering medicine into the intrathecal space.
In addition, market players are also focusing on developing software that can help clinicians in effectively managing targeted drug delivery through intrathecal pumps. In January 2020, Medtronic launched cloud-based data management software Efficio for SynchroMed II, which helps in connecting patient dosing trends for providing better management therapy.
Reasons to subscribe to U.S. intrathecal pumps market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. intrathecal pumps market databook
-
Our clientele includes a mix of intrathecal pumps market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. intrathecal pumps market, including forecasts for subscribers. This country databook contains high-level insights into U.S. intrathecal pumps market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. intrathecal pumps market size, by type, 2017-2030 (US$M)
U.S. Intrathecal Pumps Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
